Impact of Adiponectin and Leptin on Long-Term Adverse Events in Japanese Patients With Acute Myocardial Infarction - Results From the Nagoya Acute Myocardial Infarction Study (NAMIS) -
Impact of Adiponectin and Leptin on Long-Term Adverse Events in Japanese Patients With Acute Myocardial Infarction - Results From the Nagoya Acute Myocardial Infarction Study (NAMIS) -
复制标题
DOI:
10.1253/circj.cj-13-0251
复制
发表时间:
2013-11-01
影响因子:
3.3
通讯作者:
Murohara, Toyoaki
中科院分区:
文献类型:
--
作者:
Morita, Yasuhiro;Maeda, Kengo;Murohara, Toyoaki
Background: Low adiponectin levels and high leptin levels are associated with a high incidence of developing cardiovascular disease. However, the relationship between the levels of these adipokines and the development of adverse events after acute myocardial infarction (AMI) remains unclear.Methods and Results: This study enrolled 724 Japanese subjects with AMI who underwent successful emergency percutaneous coronary intervention (PCI). Their serum adiponectin and leptin levels were measured 7 days after AMI onset. There were 63 adverse events during the 3-year follow-up. The levels of adiponectin and leptin and the leptin to adiponectin ratio, were significantly associated with adverse events [hazard ratio 2.08 (95% confidence interval (CI) 1.33-3.24), P=0.001; hazard ratio 0.62 (95% CI 0.43-0.90), P=0.012; hazard ratio 0.59 (95% CI 0.45-0.76), P